HistogenHSTO

Histogen

Histogen Inc is a clinical-stage therapeutics company focused on developing proprietary hypoxia-generated growth factor technology platforms and stem cell-free biologic products as potential first-in-class restorative therapeutics that ignite the body's natural process to repair and maintain healthy biological function.

Ratings

0 / 5

0 ratings in the last 12 months

5
4
3
2
1
CEO
Dr. Steven J. Mento,PhD

2005

(há 19 anos)
Fundação

2020

(4 years ago)
IPO

NASDAQ

Listagem
Flag of US

San Diego

Sede • California

7

N° de Empregados • 2022

Valuation

Valuation Indicators

Retorno Histórico

HSTOSó no Premium...

Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.

30%

1 dia

02/10/2023

30%

1 semana

27/09/2023

-2%

1 mês

05/09/2023

-53%

1 ano

04/10/2022

-100%

5 anos

04/10/2018

10 anos

Histórico